Holen Sie sich die Stockscreener-App
1.605
0.31%
-0.005
Handel nachbörslich:
1.60
-0.005
-0.31%
Schlusskurs vom Vortag:
$1.61
Offen:
$1.58
24-Stunden-Volumen:
133.46K
Relative Volume:
0.62
Marktkapitalisierung:
$86.21M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-31.39M
KGV:
-1.9107
EPS:
-0.84
Netto-Cashflow:
$-18.45M
1W Leistung:
+4.22%
1M Leistung:
-1.53%
6M Leistung:
+9.18%
1J Leistung:
+129.29%
1-Tages-Spanne:
$1.57
$1.65
1-Wochen-Bereich:
$1.4717
$1.65
52-Wochen-Spanne:
$0.675
$2.45
Quince Therapeutics Inc Stock (QNCX) Company Profile
Firmenname
Quince Therapeutics Inc
Sektor
Branche
Telefon
415-910-5717
Adresse
611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO
Vergleichen Sie QNCX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QNCX
Quince Therapeutics Inc
|
1.605 | 85.94M | 0 | -31.39M | -18.45M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Quince Therapeutics Inc Stock (QNCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-05 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-03-24 | Eingeleitet | Oppenheimer | Outperform |
Quince Therapeutics Inc Aktie (QNCX) Neueste Nachrichten
Can Quince Therapeutics Inc. continue delivering strong returnsAnalyst Downgrade & High Accuracy Swing Trade Signals - khodrobank.com
Analyzing drawdowns of Quince Therapeutics Inc. with statistical toolsJuly 2025 Breakouts & Detailed Earnings Play Strategies - Newser
Quince Therapeutics Inc. stock momentum explainedBond Market & Real-Time Stock Movement Alerts - Newser
Real time social sentiment graph for Quince Therapeutics Inc.Recession Risk & Real-Time Market Trend Scan - Newser
Is Quince Therapeutics Inc. stock bottoming out2025 Short Interest & Verified Short-Term Trading Plans - Newser
Applying big data sentiment scoring on Quince Therapeutics Inc.2025 Big Picture & Safe Entry Zone Identification - Newser
Analyzing Quince Therapeutics Inc. with multi timeframe chartsTrade Exit Report & Safe Capital Growth Tips - Newser
Momentum divergence signals in Quince Therapeutics Inc. chartQuarterly Profit Review & Target Return Focused Stock Picks - Newser
Is now a turning point for Quince Therapeutics Inc.July 2025 Volume & Daily Stock Trend Watchlist - Newser
Published on: 2025-09-03 04:49:09 - Newser
Published on: 2025-09-03 04:36:47 - Newser
Is it time to cut losses on Quince Therapeutics Inc.Trade Risk Assessment & Growth Oriented Trading Recommendations - Newser
How high can Quince Therapeutics Inc. stock goMarket Activity Report & Technical Pattern Based Signals - Newser
Quince Therapeutics Inc.’s volatility index tracking explainedEarnings Summary Report & Real-Time Buy Signal Alerts - Newser
How to interpret RSI for Quince Therapeutics Inc. stockPortfolio Growth Summary & Community Shared Stock Ideas - Newser
Ranking Quince Therapeutics Inc. among high performing stocks via toolsMarket Activity Summary & Capital Protection Trade Alerts - Newser
Technical analysis overview for Quince Therapeutics Inc. stockExit Point & Low Drawdown Trading Strategies - Newser
Is Quince Therapeutics Inc. a strong candidate for buy and holdJuly 2025 Macro Moves & Weekly High Potential Stock Alerts - khodrobank.com
Using data filters to optimize entry into Quince Therapeutics Inc.2025 Earnings Impact & Precise Swing Trade Alerts - Newser
How moving averages guide Quince Therapeutics Inc. tradingJuly 2025 Analyst Calls & Short-Term High Return Ideas - Newser
Candlestick signals on Quince Therapeutics Inc. stock todayJuly 2025 Snapshot & Reliable Intraday Trade Alerts - Newser
Quince Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference - BioSpace
Quince Therapeutics’ Strategic Momentum in Rare Disease Innovation - AInvest
What’s the outlook for Quince Therapeutics Inc.’s sectorWeekly Gains Summary & Safe Entry Trade Reports - khodrobank.com
What is the earnings history of Quince Therapeutics Inc.2025 EndofYear Setup & Free Reliable Trade Execution Plans - khodrobank.com
Can machine learning forecast Quince Therapeutics Inc. recoveryJuly 2025 Opening Moves & Pattern Based Trade Signal System - Newser
Aug Outlook: Does Quince Therapeutics Inc. align with a passive investing strategyJuly 2025 Technicals & Free Weekly Chart Analysis and Trade Guides - khodrobank.com
Published on: 2025-09-01 11:59:42 - Newser
Will Quince Therapeutics Inc. Benefit From Sector TailwindsJuly 2025 Intraday Action & Free Weekly Chart Analysis and Trade Guides - beatles.ru
Technical Charts Suggest Momentum Shift in Quince Therapeutics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Smart tools for monitoring Quince Therapeutics Inc.’s price actionJuly 2025 PreEarnings & Real-Time Buy Zone Alerts - Newser
Should you hold or exit Quince Therapeutics Inc. nowInflation Watch & Risk Controlled Stock Pick Alerts - Newser
Is Quince Therapeutics Inc. a candidate for recovery play2025 AllTime Highs & Technical Analysis for Trade Confirmation - Newser
New Product Launches: Will They Boost Quince Therapeutics Inc. Stock in 2025Forecast Cut & Fast Exit/Entry Strategy Plans - Newser
Is this a good reentry point in Quince Therapeutics Inc.Portfolio Risk Summary & Low Drawdown Trading Techniques - Newser
Heatmap analysis for Quince Therapeutics Inc. and competitorsJuly 2025 Institutional & Safe Investment Capital Preservation Plans - Newser
Can Quince Therapeutics Inc. be the next market leaderPortfolio Gains Summary & Weekly High Return Forecasts - 선데이타임즈
Building trade automation scripts for Quince Therapeutics Inc.Weekly Trade Analysis & Accurate Buy Signal Alerts - Newser
Historical volatility pattern of Quince Therapeutics Inc. visualizedAnalyst Upgrade & Community Supported Trade Ideas - Newser
Finanzdaten der Quince Therapeutics Inc-Aktie (QNCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):